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Osteochondral tissue engineering has shown an increasing development to provide suitable strategies for the regeneration of damaged cartilage
and underlying subchondral bone tissue. For reasons of the limitation in the capacity of articular cartilage to self-repair, it is essential to develop
approaches based on suitable scaffolds made of appropriate engineered biomaterials. The combination of biodegradable polymers and bioactive
ceramics in a variety of composite structures is promising in this area, whereby the fabrication methods, associated cells and signalling factors
determine the success of the strategies. The objective of this review is to present and discuss approaches being proposed in osteochondral tissue
engineering, which are focused on the application of various materials forming bilayered composite scaffolds, including polymers and ceramics,
discussing the variety of scaffold designs and fabrication methods being developed. Additionally, cell sources and biological protein incorporation
methods are discussed, addressing their interaction with scaffolds and highlighting the potential for creating a new generation of bilayered com-
posite scaffolds that can mimic the native interfacial tissue properties, and are able to adapt to the biological environment.
Keywords: osteochondral tissue engineering bilayered scaffolds scaffold designs scaffold
fabrication composites clinical relevance
Introduction
Recent studies in the field of engineering of tissue interfaces [1–3]
are leading to promising approaches for the regeneration of a variety
of interface tissue defects, especially the cartilage–bone (osteochon-
dral) interface [2]. Osteochondral defects affect both the articular
cartilage and the underlying subchondral bone. Cartilage can be dis-
tinguished into four distinct zones: superficial, middle, deep and calci-
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fied cartilage zones, as depicted in Figure 1. Each zone is defined by a
particular composition and organization of cells and extracellular
matrix (ECM) molecules, with different proportions of ECM compo-
nents significantly influencing the mechanical properties of each area
[4, 5]. For example, the compressive modulus of superficial, middle
and deep zones is 0.079, 2.1 and 320 MPa, respectively, indicating
the notable differences in stiffness of this tissue. Bone is a complex
tissue consisting of water, collagen type I and hydroxyapatite crys-
tals, with the two latter components providing the tissue’s stiffness
and compressive strength [4, 6]. The compressive modulus of
subchondral bone (5.7 GPa) is higher than that of cartilage. The
different compositions and mechanical properties of bone and
cartilage indicate the complexity of this tissue interface, making it
challenging for the design and fabrication of tissue engineering
scaffolds [4, 7].
Osteochondral composite scaffolds are being considered for res-
toration of the biological and mechanical functionality of the bone–
cartilage interface [2, 4, 8]. Specific biomaterial-based strategies are
being proposed, including (I) different scaffolds for the bone and car-
tilage sides combined at the time of implantation, (II) a scaffold for
the bone component, but a scaffold-free approach for the cartilage
side, (III) a single homogeneous scaffold for both components and
(IV) a single but heterogeneous composite scaffold [2, 9]. Moreover,
interface tissue engineering requires biocompatible and biodegrad-
able scaffolds with highly porous microstructures for cell attachment,
proliferation and stimulation of cell growth. Several biomaterials are
being investigated for interface tissue engineering, including natural
materials such as proteins or carbohydrate-based polymers, including
collagen, hyaluronan and chitosan, and synthetic materials such as
bioactive ceramics and a wide range of synthetic polymers [4, 5, 10–
19]. Natural materials may enhance biological interaction with host
tissues. However, the clinical applications of such natural materials
are still difficult to realize with current technologies because of their
relative mechanical inferiority and instability compared with native
cartilage [15]. In contrast, synthetic materials, whilst lacking the
intrinsic biocompatibility of natural materials, have important advan-
tages, including some control of chemical, mechanical and structural
properties of the scaffold and the possibility of satisfying the increas-
ing clinical demand. Within the group of synthetic materials, bioactive
ceramics such as hydroxyapatite (HA), calcium phosphates (CaP) and
silicate bioactive glasses are being widely used in bone tissue engi-
neering because of their excellent osteoconductive/osteoinductive
capabilities [20–24]. However, synthetic biodegradable polymers,
such as poly(caprolactone) (PCL) and, in particular, poly(a-hydroxy
esters): poly(lactic acid) (PLA), poly(glycol alcohol) (PGA), and the
copolymer of poly(lactic acid) and poly(glycol alcohol) (PLGA), are
widely used in cartilage tissue engineering [2, 9].
Osteochondral tissue engineering requires a unique composition
and organization of the scaffold, specific biological properties and
mechanical requirements. This complexity has led to the development
of bilayered scaffolds, the potential candidates for osteochondral tis-
sue engineering, which should ideally promote individual growth of
both cartilage and bone layers within a single integrated implant.
Recent studies have incorporated homogeneous and heterogeneous
bilayered biomaterial scaffolds within in vitro and in vivo environ-
ments, which will be discussed in the following sections. This review
article will thus analyse osteochondral tissue engineering scaffolds,
focusing on bilayered composite scaffolds, concerning materials,
scaffold designs and fabrication methods. A discussion is provided
on the relative advantages and disadvantages of the different con-
cepts proposed highlighting promising avenues for further research.
Scaffolds for osteochondral tissue
engineering
Requirement of scaffolds for osteochondral
tissue engineering
It is generally accepted that scaffolds in tissue engineering operate as
an artificial, and sometimes, temporary ECM, mimicking the structure
and functionality of the native ECM, to physically guide or chemically
inform cell response and thus promote tissue growth [9]. Osteochon-
dral tissue engineering involves the combination of cartilage and
subchondral bone, which have significant differences in biological
structure, composition and mechanical properties. Additionally, carti-
lage tissue shows limitation in self-regeneration because the tissue is
avascular and not innervated [25]. Generation of tissue-engineered
Fig. 1 Schematic diagram of osteochondral tissue: (A) histological appearance of the osteochondral transition in rabbit articular cartilage (toluidine blue
staining, 910 magnification) (Image courtesy of Dr. Cathal O’Flatharta (Regenerative Medicine Institute, Galway, Ireland)); and (B) a diagram depicting
the cartilage–bone interface.
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osteochondral graft requires living cells and substitutes for the ECM
in both cartilage and subchondral bone [26]. The tissue-engineered
osteochondral scaffold should integrate with host tissue and maintain
cell survival and phenotype during in vivo implantation. Mesenchymal
stem cells (MSCs) have been suggested for osteochondral tissue
engineering [27–29]. The correct selection of biomaterials, scaffold
design and fabrication methods are crucial for the successful devel-
opment of suitable scaffolds in an attempt to cope with the require-
ments of both cartilage and subchondral bone, and also to eliminate
the problems of other approaches that include inappropriate donor
tissue, immune rejection and pathogen transfer. The function of artic-
ular cartilage depends partly on the mechanical support of subchon-
dral bone. An added complexity of scaffolds for osteochondral tissue
engineering is that the subchondral matrix should have structure
mimicking cancellous bone with suitable mechanical strength to with-
stand compressive loads and have ability to bond to the softer mate-
rial used to regenerate the articular cartilage [26]. As in all tissue
engineering strategies, it is necessary that the osteochondral scaf-
folds are highly porous with an interconnected 3-dimensional pore
network for cell growth and transport of nutrients and removal of
subsequent metabolic waste. The scaffold’s architecture defines the
ultimate shape of the newly formed cartilage and bone [12]. Scaffolds
fabricated from biocompatible materials should not elicit immunologi-
cal or foreign body reactions. Furthermore, scaffolds have to be cho-
sen to be degraded and be resorbed at a controlled rate at the same
time as cells seeded into the 3D construct attach, spread and prolifer-
ate, e.g. forming new tissue [12]. Osteochondral scaffolds should
have suitable surface chemistry and topography for cell attachment,
proliferation and differentiation, and the mechanical properties of
osteochondral scaffolds must be tailored to match those of the host
tissues at the site of implantation.
Materials for osteochondral scaffolds
Current osteochondral-based research concepts are centred on the
use of four major groups of materials: natural and synthetic poly-
mers, metallic materials, inorganic materials (ceramics, glasses) and
composites of these.
Natural polymers. Natural polymers, such as collagen, glycosami-
noglycan, chitosan, starch, hyaluronic acid, alginate and bacterial-
sourced poly(hydroxyalkanoates), are comparatively weaker and
softer materials than ceramics, but offer the advantage of flexibility to
adapt their shape to required forms through a variety of moulding
and casting techniques [4]. Moreover, natural polymers usually con-
tain specific molecular domains that can support and guide cells at
various stages of their development [10] and thus can enhance bio-
logical interaction of the scaffold with the host tissue. Petrenko et al.
[29] investigated Ca-alginate scaffolds with covalently attached gela-
tin to improve cell adhesion and proliferation. The scaffolds not only
improved adhesion and proliferation of MSCs but were also able to
affect MSCs to differentiate into osteogenic and chondrogenic cell lin-
eages. The results indicated that coupling of gelatin in alginate-based
scaffolds could be useful for bone and cartilage tissue engineering.
Wang et al. [30] studied the growth of chondrocytes-seeded 3D
porous poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx)
scaffolds for cartilage repair. PHBHHx is a promising biomaterial
because of its biocompatibility, resorbability and elastomeric proper-
ties. An in vitro study of chondrocyte-seeded PHBHHx scaffolds for
30 days showed accumulation of ECM components including colla-
gen type II. After 16 weeks of transplantation in the knee of rabbit,
cartilaginous tissue filled the defects and the constructs showed good
subchondral bone connection and surrounding cartilage infusion. It
was concluded that PHBHHx is an attractive material for cartilage tis-
sue engineering. In addition, chitosan is widely studied for cartilage
scaffolds [31–33] due to its structure is similar to glycosaminogly-
cans (GAGs) that found in ECM of articular cartilage, which influence
the modulation of morphology, differentiation and function of chon-
drocytes. Moreover, collagen-based materials [34, 35] are considered
to be a favorable biomaterial for both cartilage and bone scaffolds
due to collagen is the major matrix component in ECM; collagen type
II in articular cartilage and collagen type I in bone. However, immuno-
genic, scale-up and purification issues relevant to the clinical use of
natural polymers represent important challenges [9].
Synthetic polymers. Biodegradable synthetic polymers include
polyesters such as PLA, PGA, and PLGA, PCL, poly(propylene fuma-
rate), poly(dioxanone), polyorthoesters, polycarbonates, polyanhy-
dride and polyphosphazenes. They offer a wide range of chemistries
and processing options and they may be obtained with controlled
distribution of molecular weights [10]. The laboratory fabrication of
synthetic polymers can be scaled up to industrial-scale manufactur-
ing processing, which is a requirement to meet potential clinical
demands [9]. In general, synthetic polymers have limitations in bio-
activity because of their hydrophobic surface. Shafiee et al. [36]
investigated the potential of PVA/PCL nanofibrous scaffolds for carti-
lage tissue engineering. PVA was selected to be electrospun with
PCL to improve hydrophilicity and to support cell attachment. In an
in vitro study, PVA/PCL scaffolds showed the proliferation and chon-
drogenic differentiation of MSCs. Moreover, an in vivo study in rabbit
model, MSC-loaded PVA/PCL scaffolds supported the regeneration of
cartilage and it was observed that cartilage tissue filled full-thickness
defects. Additionally, development of biodegradable synthetic poly-
mers/bioceramic incorporated composite-based scaffolds enhanced
their hydrophilicity, bioactivity and elastic modulus, as shown in the
studies of Huang et al. [37], Blaker et al. [38] and Ngiam et al. [39].
Metallic materials. Metals have extended applications in orthopae-
dic implants such as titanium, titanium alloys, stainless steels and
Cobalt-base alloys [40]. In osteochondral tissue engineering, metallic
biomaterials have been used as the subchondral bone part in bilay-
ered scaffolds, which have capability of withstanding compressive
loads and ability to bond to the softer material used as scaffold for
the cartilage part. For example, in the study of Bal et al. [26], porous
tantalum metal was bonded with PEG hydrogel loaded with MSCs
forming a bilayered osteochondral construct. After implantation in
defects of rabbit knees for 12 weeks, porous tantalum induced
growth of subchondral bone and showed integration to adjacent host
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bone. Regeneration of hyaline cartilage-like tissue and expression of
collagen type II in the articular cartilage were observed. In addition,
the MSC-seeded tantalum constructs showed both osteoconductivity
and osteoinductivity. Stem cell-coated titanium implants have been
also investigated to provide a basis for the treatment of large osteo-
chondral defects [26]. However, disadvantages of metallic materials
in tissue engineering applications are their lack of degradation over
time and the possibility of release of wear particles or corrosion prod-
ucts [40].
Inorganic materials. Ceramics, such as HA or other calcium phos-
phates, such as TCP and bioactive glasses, such as Bioglass®, are
known to promote biomineralization and they are widely used in bone
tissue engineering [2, 12, 41]. When implanted, these materials pro-
mote the formation of a bone-like apatite layer on their surface, lead-
ing to bone-bonding behaviour and assuring enhanced fixation of the
scaffold to the host tissue. These materials have excellent osteocon-
ductivity and osteoinductivity. For instance, Mastrogiacomo et al.
[42] suggested that 100% HA porous scaffolds have good osteocon-
ductive properties resulting in enhanced bone formation. After
implanting MSC-seeded scaffolds in a murine model, it was observed
that bone was formed and the amount of bone formed increased with
culture time. Additionally, bone formation was enhanced on scaffolds
with higher porosity and exhibited a higher degree of interconnection
among pores. This study concluded that HA is a promising biomate-
rial for bone reconstruction [42]. Ideal scaffolds for bone repair
require an internal architecture similar to that of natural bone to pro-
mote cell proliferation and cell ingrowth into the structure. Leukers
et al. [22] used a 3D printing technique to fabricate scaffolds based
on HA with complex internal structure. From the in vitro study of cell-
seeded scaffolds, it was confirmed that cells could proliferate deep
into the structure of the HA scaffolds without clogging. Xynos et al.
[43] used 45S5 Bioglass®-based scaffolds to enhance bone formation
by the effect of ion dissolution products (Hoppe et al. [44]). It was
found that these scaffolds induced osteoblast proliferation and differ-
entiation. These findings confirmed the applications of Bioglass® in
bone tissue engineering where the Bioglass® substrate is proposed
as a template for the formation of bioengineered bone tissue. In this
context, Bioglass®-based scaffolds have been fabricated by the foam
replication method, exhibiting pore structure resembling cancellous
bone [45]. In addition, an alternative bioactive glass, BG 13-93 was
studied by Jayabalan et al. [46] to investigate its effect on chondro-
cytes behaviour and its use in cartilage regeneration. A porous BG
13-93-based scaffold was used as a subchondral substrate and
chondrocyte-loaded agarose was used as cartilaginous substrate in a
bilayered osteochondral construct. After culturing for 6 weeks, the
results did not follow the hypothesis that BG 13-93 substrate would
increase production of GAG and collagen in the cartilage layer. In con-
trast, cell-seeded agarose exposed to BG 13–93 showed improve-
ment of GAG and collagen production in cartilage layer. Therefore, BG
1393 was considered to have potential as a culture medium supple-
ment for cartilage regeneration, but it might be not suitable for appli-
cation as scaffold in osteochondral constructs.
Moreover, bioceramic-based scaffolds exhibit suitable stiffness,
but they have low structural integrity being brittle and unsuitable
for application under mechanical stresses. The degradation behav-
iour of inorganic scaffolds can be controlled by changes in the
porous structures, which can be tailored in terms of their degrada-
tion kinetics appropriate for bone tissue engineering. It is also well
known that increasing porosity impairs further the mechanical
properties of bioceramic scaffolds. This problem can be solved by
modifying porous inorganic scaffold with infiltration or coating by
biodegradable polymers. As shown in a study by Miao et al. [47],
porous HA/TCP scaffolds exhibited improved mechanical properties
by coating with PLGA. The coating with PLGA could improve the
compressive strength by about 10 fold compared with that of
uncoated scaffolds, whereas the porosity slightly decreased by
2%. Similar results were observed by Chen et al. [45] in a study
of PDLLA-coated 45S5 Bioglass®-based scaffolds. The compres-
sive strength was slightly improved and the work of fracture
(related to the energy required to induce fracture in the material)
was significantly enhanced by the PDLLA coating. Moreover, the
bioactivity of Bioglass®-based scaffolds was maintained after appli-
cation of PDLLA coatings. Several studies on polymer-coated inor-
ganic scaffolds for bone tissue engineering, including HA, bioactive
glass, Al2O3, TiO2, ZrO2 and CaP, have been reviewed by Yunos
et al. [48], showing that these scaffolds achieve suitable mechani-
cal properties for this application.
In osteochondral tissue engineering, biomaterials which can fulfil
the ideal requirements are still being sought. In this context, individ-
ual bioceramic-based scaffolds and pure polymer-based scaffolds
have limitations for the repair of osteochondral defects. Therefore,
new approaches based on composite materials for osteochondral tis-
sue engineering are being proposed as described below.
Cells and bioactive molecules for osteochondral
tissue engineering
In osteochondral repair, chondrogenic and osteoblastic cell lines
have been widely used for clinical applications; however, adult and
embryonic stem cells have recently received great attention [49,
50]. Stem cells are an alternative resource to overcome the limited
supply of primary cells [51]. In addition, specific signalling mole-
cules, such as growth factors (TGF-b family, insulin-like growth
factors, bone morphogenetic proteins and fibroblast growth fac-
tors), are extensively employed to facilitate tissue growth [51].
They bind to cell surface receptors and activate intracellular signal-
ling pathways, which affect cell proliferation, differentiation and
ECM synthesis during tissue regeneration [51]. Among the growth
factors, the TGF-b family could enhance the synthesis of the carti-
lage ECM in chondrocytes and induce chondrogenesis in stem
cells. Chondrocytes (articular, auricular, costa, nasoseptal) and
osteoblasts are an obvious choice because they are found in native
cartilage and bone, respectively, and are generally relatively simple
to access surgically. Sherwood et al. [52] produced bilayered scaf-
folds based on PLGA/TCP composite for the bone and PLGA/PLA
for the cartilage area, respectively, which were seeded with ovine
articular chondrocytes and cultured for 6 weeks. The results
showed the formation of cartilage, but in vivo investigations were
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not performed to verify the performance of these scaffolds. The
use of chondrocytes in such 2-dimensional in vitro systems may
have limitations in cell re-differentiation, which leads to the down-
regulation of cartilage specific genes. In this context, the reduced
capacity of expanded chondrocytes to re-differentiate and produce
cartilage-specific ECM may impair the goal of generating functional
cartilage tissue [2]. This problem can be overcome by expanding
chondrocytes in the presence of specific growth factors. For
instance, Allan et al. [53] used bovine chondrocytes with porous
CPP scaffolds and cultured them in the presence of sodium
b-glycerophosphate (Na-b-GP) for 8 weeks to generate a calcified
cartilage zone. After culturing, two layers of cartilage tissue were
observed corresponding to the hyaline-like and the calcified carti-
lage zones. When compared with the control condition, little or no
mineralization occurred without the addition of Na-b-GP. The pres-
ence of the differentiation factor during expansion of chondrocytes
showed not only to increase cell proliferation but also to enhance
the cell capacity to re-differentiate. Moreover, another approach for
osteochondral tissue engineering is to reconstruct the functional
engineered cartilage–bone interface by co-culturing chondrocytes
and osteoblasts into bilayered scaffolds, for growth and differentia-
tion of both cell types [54]. Cao et al. [55] designed and fabri-
cated 3D porous PCL scaffolds by fused deposition modelling
(FDM). Osteoblasts were seeded and precultured into one half of
the scaffold, and later chondrocytes were seeded into the other
half. After that, the cell-seeded scaffolds were cultured in a co-cul-
ture medium, both cell types proliferated, migrated and integrated
at the interface. Moreover, osteoblasts and chondrocytes produced
different ECM in each own compartment. In this approach, the
important aspect is the interactions between both cell types and
the scaffold during co-culture, and the assessment of material-
dependent effects on the formation of the functional bone–cartilage
interface. Moreover, it is critical to control both osteogenic and
chondrogenic phenotypes during co-culture to maintain each tissue
zone similar to native tissue. Stem cells (bone marrow-derived,
adipose-derived, muscle-derived, synovium-derived, periosteum-
derived, embryonic), are also significantly interesting for osteo-
chondral tissue engineering. In 1998 (Johnstone et al. [56]), MSCs
were found to undergo chondrogenesis when cultured in the pres-
ence of TGF-b1. The addition of TGF-b1 has been shown to stimu-
late chondrogenesis; however, the degree of chondrogenesis also
depends on the scaffold. Gao et al. [57] used a bilayered compos-
ite to mimic the natural tissue geometry, which was composed of
MSCs-seeded injectable calcium phosphate (ICP) and osteogenic
supplement for bone regeneration and a hyaluronan layer seeded
with MSCs and TGF-b1 for cartilage regeneration. After 12 weeks
of implantation, the composites displayed collagen type I in neotis-
sue in both components and collagen type II in fibrocartilage. This
composite osteochondral graft showed that its construction of dif-
ferent biomaterials and bioactive factors can support either chon-
drogenic or osteogenic differentiation of MSCs. Alhadlaq et al. [58]
prepared osteochondral scaffolds with PEG hydrogel seeded with
rat MPCs. After 4 weeks of implantation in mice, most differenti-
ated chondrogenic and osteogenic cells had synthesized both cor-
responding cartilaginous and bone-like ECM. Overall, the ideal cell
source must be easily isolated, capable of expansion, and cells
should be cultured to express and synthesize at least aggrecan
and collagen type II on the cartilage region, and provide minerali-
zation on the bone region. Moreover, growth factors have been
used to induce cell proliferation and extracellular molecules synthe-
sis in culture [14]. In a study by Huang et al. [59], an implant
comprising PCL scaffold, MSCs and TGF-b1 growth factor-loaded
fibrin glue was investigated to assess the induction of cartilage
formation when implanted in a lapine model. It was found that at
4 weeks after implantation, the scaffolds were richly populated
with chondrocytes and immature bone was identified at 6 weeks
after implantation because of the presence of growth factors that
acted as recruitment agents to attach cells to the site. Tradition-
ally, TGF-b1 has been regarded a cartilage-inducing factor as well
as a bone-inducing factor. Abrahamsson [60] prepared 3D woven
scaffolds based on PCL seeded with human MSCs and cultured in
the presence of human TGF-b3 growth factor to analyse chondro-
genesis and mineralization on osteochondral scaffolds. After cul-
ture for 21 days, formation of cartilaginous tissue was observed.
Mineralization was observed in the newly formed ECM at the inter-
face with the underlying scaffold by day 45. The construct after
implantation for 45 days also showed mechanical properties similar
to those of native articular cartilage. These findings merit consider-
ation when developing grafts for osteochondral defect repair. Over-
all, MSCs are an attractive cell source for osteochondral tissue
engineering [27, 61]. Especially, these cells provide higher prolifera-
tive capacity and have ability to differentiate into osteoblasts or
chondrocytes in different simulative environments, [62] although
they yield lower initial cell numbers compared with primary cells [6,
10, 11]. The primary cells (chondrocytes and osteoblasts) might
have limitation in their use because of more risk of causing pheno-
typic changes and age-dependent proliferative capacity [6]. Never-
theless, chondrocyte hypertrophy in neocartilage (e.g. collagen type
X) could be expressed by MSCs undergoing chondrogenesis without
any bioactive factors, which results in apoptosis, vascular invasion
and ossification [28]. Thus, the interaction between specific cells
and material substrates, and the effect of bioactive factors or sup-
plements must be carefully investigated in this area.
Scaffold designs for osteochondral
tissue engineering
The bilayered scaffold approach
The scaffold design is paramount for the success of osteochondral
tissue engineering, being necessary to consider the scaffold micro-
structure, surface topography, porosity, pore geometry and orienta-
tion, biodegradability and mechanical properties of scaffolds. These
scaffold characteristics dictate the ability of the scaffold to resist
mechanical loading and influence the associated tissue regeneration.
As a result of bone and cartilage having uniquely different composi-
tions, tissue growth mechanisms and metabolic requirements,
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respectively, bilayered composite structures have been developed to
exploit and combine the advantages of various individual materials.
Bilayered scaffolds allow for creation of optimized tissue-specific bio-
logical environments in each layer via variation of the local mechani-
cal, structural and chemical properties. In addition, bilayered
scaffolds can be designed to mimic the native ECM for each tissue
type independently, which may be more convenient than intending
the fabrication of monolithic constructs with different functional
requirements of both bone and cartilage in a single structure [9].
Bilayered scaffolds have been classified into four types [2, 9], as
mentioned above. The summary of various approaches being
followed in the design of bilayered composite scaffolds, including
materials and fabrication methods, is shown in Table 1.
Scaffolds for individual bone and cartilage tissue
regeneration combined at the time of
implantation
Because of the markedly different tissue properties at the interface
between cartilage and subchondral bone, different scaffolds can be
used individually for cartilage and bone components. If bioreactors
are used, they allow the cultivation of both chondrogenic and osteo-
genic cells in separate environments [63]. Then, constructs for carti-
lage tissue and bone tissue developed separately are combined into a
single composite graft by suturing or adhering two layers together, as
shown in Figure 2 (I). The main disadvantage of this approach is that
integration between the two layers may not be satisfactory [10].
Schaefer et al. [64] investigated the use of 3D cartilage/bone com-
posites based on biodegradable polymer scaffolds combined with
chondrogenic and osteogenic cells. Cartilage constructs were created
by PGA meshes cultured with bovine calf articular chondrocytes.
Bone constructs were created by the blend of PLGA and PEG cultured
with bovine calf periosteal cells. Pairs of constructs were sutured
together after 1 or 4 weeks of isolated culture, then the resulting
composites were cultured for additional 4 weeks. It was found that
the osteochondral composites generated by suturing were stable and
did not separate upon removal of the sutures at the time of harvest.
From the histological assessment, the accumulation of GAG showed a
higher scattered area at 4 weeks culture time in comparison with that
at 1 week culture time. In the region of bone, no evidence of minerali-
zation was found after 1 week, whereas there was mineralization after
culturing for 4 weeks. Therefore, the amount of GAG and mineraliza-
tion was confirmed to increase with cultured time. After 1 week of
culture of the cartilage compartment combined with 1 week of culture
of the bone compartment and with additional culture of the compos-
ites for 4 weeks, good integration at the tissue interface was found.
In contrast, composites obtained from the combination of 4 weeks
culture of cartilage and 4 weeks culture of bone separately showed
poor integration at the interface, although more continuous ECM-con-
taining GAG was observed in the cartilage region of both composites
after additional 4 weeks of combined culture. This study concluded
that newly produced cartilage and bone tissues affected integration at
the cartilage–bone interface. The combination of immature cartilage-
like construct (after 1 week in isolated culture) and mature bone-like
construct (after 4 weeks in isolated culture) was seen to be effective
to form a composite construct and to promote integration at the inter-
face. Gao et al. [57] demonstrated the potential of using an ICP for
the bone layer and a hyaluronan (HyA) sponge seeded with MPCs for
the cartilage layer. After 12 weeks of implantation in a lapine model,
the osteochondral defect was filled almost 100% with repair tissue
and the HyA part was resorbed by 10 weeks. Zonal arrangement,
including superficial, chondroid tissue, and interface layers, appeared
to take place in the neo-cartilaginous tissue [57]. Significantly, the
two-phase composite construct showed great integration at the inter-
face between HyA and ICP components, ascribed to the local mechan-
ical stress. The compressive load of the joint was applied and
transmitted through the HyA sponge, ICP component and the bottom
of the defect. The counteracting load was generated upwards and lat-
erally, and induced the infiltration of ICP into the pores of the HyA
sponge, leading to interface integration. Moreover, the laterally coun-
teracting load was expanded laterally by the HyA sponge, causing a
contact between the sponge and the surrounding native cartilage.
Shao et al. [65] attempted to evaluate the repair potential in osteo-
chondral defects (high load-bearing sites) by using hybrid scaffolds
with MSCs in a lapine model. The scaffolds comprised PCL for the
cartilage component and TCP-reinforced PCL for the bone compo-
nent. The scaffolds were seeded with MSCs in each part and placed in
osteochondral defects of lapine models by press-fit implantation.
Repair tissues were evaluated at 12 and 24 weeks after implantation
[65]. Compared with the control group (without cells), the PCL/PCL-
TCP scaffolds showed superior repair ability in both bone and carti-
lage parts, indicating that the hybrid scaffolds provided sufficient
support to new osteochondral tissue formation. From a period of 12–
24 weeks, bone generation led to the firm integration to host tissue.
After 24 weeks of implantation, subchondral bone filled the scaffold,
which showed good integration with the host bone. Moreover, carti-
lage tissue exhibited GAG and collagen type II deposition. However,
the cell arrangement in new cartilage tissue lacked zonal organization.
The Young’s modulus of the neotissue–polymer matrix construct at
24 weeks after implantation (~0.76 MPa) approached that of normal
cartilage of mature rabbits (~0.81 MPa) [65]. The authors stated that
this phenomenon could have been caused by the slow degradation of
PCL-based hybrid scaffolds, which might leave remnants in the repair
space over time and these remnants could help maintain sufficient
mechanical support for subchondral bone and neocartilage. However,
the possible changes in the scaffold and repair tissues over longer
times of implantation were not shown in the study [65]. Neocartilage
that deteriorates with time may happen, as shown in the study of Chu
et al. [66]. Neocartilage in the region of repair tissue in rabbit
decreased from 95% at 12 weeks to only 29% at 1-year follow-up
[66, 67]. Scotti et al. [68] generated osteochondral composites
including collagen-containing human chondrocytes for the cartilage
part and fibrin gel for the bone part. It was shown that the separate
cell pre-culture before generation of the composite allowed more effi-
cient cartilaginous matrix accumulation than without pre-culture.
Moreover, good biological bonding of the chondral scaffold with the
bony scaffold by the cell-laid ECM occurred, indicating a suitable
mechanical integrity at the interface and the possibility of effective
2252 ª 2012 The Authors
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surgical handling. Chen et al. [69] formulated a bilayered scaffold for
simultaneous regeneration of cartilage and bone using gene delivery
system to induce the growth of MSCs. Plasmid TGF-b1 activated
chitosan/gelatin (CG) porous scaffold and Plasmid BMP-2 activated
hydroxyapatite/chitosan/gelatin porous (HCG) scaffold were fabri-
cated for the cartilage and bone regions, respectively. Both scaffolds
were seeded with MSCs separately before integrated with fibrin glue.
The interface of the bilayered scaffold showed good integration as a
result of the interdigitation of the chondral phase into the osseous
phase. After 2 weeks of co-culture, it was found that pTGF-b1 and
pBMP-2 can induce MSCs in each layer to differentiate into chondro-
genic and osteogenic-like cells. This demonstrated that the localized
delivery system of DNA as tissue inductive factors in bilayered scaf-
folds could facilitate the differentiation of stem cells into specific cell
types to develop complex tissues. An in vivo study in a rabbit model
showed that the gene delivery system utilized in this bilayered con-
struct simultaneously supported cartilage and bone regeneration, pre-
senting a promising strategy for facilitating the development of
osteochondral tissue [68].
In summary, scaffolds for individual bone and cartilage tissue
regeneration combined at the time of implantation represent one of
the scaffold designs for osteochondral repair, based on the combina-
tion of different materials and cells specified for individual cartilage
and subchondral bone tissues or different biological factors to induce
the differentiation of stem cells into chondrocytes and osteoblasts.
Pre-culture of individual scaffolds with relevant cells is an important
step. Also, the isolated culture period affects integration at the inter-
face between cartilage and bone parts. Thus, most studies have
shown that good integration at the cartilage–bone interface was
achieved by biological bonding of newly formed ECM produced by
cell-seeded scaffolds [68, 70]. Therefore, immature cartilage or bone-
like tissue constructs should be chosen for forming composite con-
structs before in vivo implantation. Also, the cartilage–bone interface
can be improved by local mechanical loading of the joint. Moreover,
this load can help achieve good contact between neotissue and host
tissue. However, the degeneration of new formed cartilaginous tissue
has been observed with longer implantation times [66, 67, 71]. One
of the reasons for this result was considered to be biomechanical
incompatibility occurring at the defect site, for example, low stiffness
and fast degradation rate of the materials used [68]. This problem
can be overcome by appropriate biomaterials, which have biocompat-
ibility, tailored degradation rate, and sufficient strength over a long
enough period of time to withstand in vivo physiological forces.
Finally, a limitation of this strategy could be the labour-intensive work
related to in vitro culture of engineered cartilage for 4 or 6 weeks
[70], and it may not be convenient for further clinical application.
Scaffolds for bone component and scaffold-free
approach for cartilage component
Instead of using two scaffold structures, this family of bilayered scaf-
folds incorporates neocartilage tissue that has been grown in vitro
from seeded chondrocytes on the top of a subchondral support to
form the secondary layer [53], as shown in Figure 2 (II). This design
therefore requires a suitable engineered material to support subchon-
dral bone and to allow the induction of neocartilage tissue. There are
many approaches which focus on biomaterials for this type of scaf-
Fig. 2 Schematic diagram of bilayered
scaffolds, including (I) scaffolds for indi-
vidual bone and cartilage tissue regenera-
tion combined at the time of implantation,
(II) scaffold for bone component and scaf-
fold-free approach for cartilage compo-
nent, (III) single and homogeneous
scaffolds and (IV) single but heteroge-
neous scaffolds (Modified from Mano
et al. [10]).
ª 2012 The Authors 2257
Journal of Cellular and Molecular Medicine ª 2012 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
J. Cell. Mol. Med. Vol 16, No 10, 2012
fold that include bioceramics, such as HA, Bioglass®, calcium sul-
phate and CaP, natural polymers, such as collagen and chitosan, and
synthetic polymers, such as PLLA, PDLLA and PGA. Wang et al. [72]
explored various candidate biodegradable support materials onto
which neocartilage was produced in vitro. PLLA, PDLLA and collagen-
hydroxyapatite (Col-HA) were seeded with chondrocytes and cultured
in a closed and static bioreactor for 15 weeks. It was found that neo-
cartilage formed onto all types of biomaterial supports. PLLA and Col-
HA scaffolds were still in disc form after 15 weeks culture, whereas
the PDLLA scaffolds were not regular in shape because of the col-
lapse of the PDLLA structure, after 11 weeks in culture. As a result of
the degradation of PDLLA, the highest amount of cell death was
observed, indicating that this material might not be ideal for implanta-
tion, even though after removal from the chamber, the material was
stable enough to be handled by forceps. In the study of Wang et al.
[72], the composite Col-HA showed the lowest rate of degradation
and the lowest number of dead cells. Moreover, cell ingrowth was
observed, while there were only a few cells observed inside PLLA
scaffolds. Neocartilage in Col-HA scaffolds also displayed collagen
fibrils, which were well connected between cartilage tissue and sub-
chondral bone-like tissue at the interface. It can be concluded that
under the conditions of the study [72], Col-HA composite was supe-
rior in comparison with PLLA and PDLLA in terms of cell viability,
construct shape and cellular integration. However, it is yet to be
determined if this material is adequate for implantation from the
mechanical point of view because of the loads experienced at the
joint. It was predicted that superficial binding may lead to implant
delamination. Guo et al. [73] prepared b-TCP-based scaffolds as sub-
chondral bone construct, which was tested in a sheep model. The
b-TCP porous ceramics were proposed because of their faster resorp-
tion potential compared with HA. Chondrocytes were seeded into 3D
scaffolds to create cell-scaffold constructs and to evaluate their effi-
cacy for cartilaginous tissue generation. The characteristics of these
scaffolds included homogeneous porosity of 70%, spherical pores of
450 ± 50 lm in diameter and interconnections of 150 ± 50 lm in
diameter. From histological examination, chondrocyte proliferation
and neocartilage colonization were found inside the pores. The
defects (ovine model) were entirely filled with neocartilage tissue
within 24 weeks after implantation. Furthermore, b-TCP scaffolds
exhibited many desired properties, such as performance stability,
good compatibility, relatively high mechanical strength, suitable mac-
rostructure, excellent osteoconduction and biodegradation properties.
However, it was recommended that long-term in vivo observations of
the host tissue response to the scaffolds should be made to validate
the approach. In addition, the stability of repaired cartilage should be
further investigated. Kandel et al. [74] developed osteochondral con-
structs by using porous calcium polyphosphate (CPP) as a substrate
to grow articular cartilage on the surface. The CPP scaffolds were
seeded with chondrocytes and studied in vivo in an ovine model. After
implantation, there was evidence that the implant could withstand
loading up to 36 weeks and it was fixed by adjacent native cartilage
and bone ingrowth in the CPP substrate. However, some implants in
this study showed that the cartilaginous tissue delaminated during
the 12–16 weeks of implantation period because of a low cartilage/
CPP interfacial shear strength in comparison with the native osteo-
chondral interface [74, 75]. Li et al. [76] prepared demineralized bone
matrix gelatin (BMG)-based scaffolds for osteochondral tissue engi-
neering, which were cultured with rabbit chondrocytes to produce
neocartilage. It was found that neocartilage of about 1.3 mm thick-
ness was produced on the BMG scaffold after 6 weeks of in vitro cul-
ture. Hyaline-like cartilage, intense collagen type II and abundant
proteoglycan were observed, whereas collagen type I and protein
expression were significantly low. Moreover, it was found that the
interface between cartilage and the BMG scaffold remained a weak
area, caused by the fact that BMG scaffolds do not have a structure
like subchondral bone that could allow chondrocytes to grow into the
porous structure and form the calcified cartilage layer [76]. Allan
et al. [53] attempted to mimic the structural arrangement of the ECM
by forming a zone of calcified cartilage, using biphasic constructs
composed of cartilaginous tissue anchored to the top surface of the
bone substitute that was a porous CPP with calcified interface. When
cultured in the presence of Na-b-GP for 8 weeks, a two-layered carti-
lage tissue (calcified cartilage (interface) and hyaline-like zones) was
observed. In terms of mechanical properties, the equilibrium stress
increased with the presence of a calcified interface zone, as shown in
Table 2. Also, the equilibrium modulus, indicating tissue stiffness, of
the neocartilage with a mineralized zone was significantly greater than
that of the in vitro-formed tissue without mineralization. In addition,
the interfacial shear properties at the cartilage-CPP scaffold were
enhanced as a result of the efficient integration of hyaline-like carti-
lage and the CPP scaffold by the calcified cartilage layer. This result
demonstrated the importance of the presence of a mineralized zone in
bioengineered cartilage. Kitahara et al. [77] studied the in vivo perfor-
mance of HA as subchondral bone scaffold for articular cartilage
repair. The HA scaffolds were seeded with alginate-recovered-chon-
drocytes (ARC) to generate cartilage tissue for osteochondral repair.
Then, bilayered scaffolds were implanted in mice. At 8 weeks of
implantation, the chondrocytes were well distributed in the interface
area and expression of collagen type II was observed particularly in
the local area around the chondrocytes. Moreover, histological results
showed a massive area of GAG from the surface to the interior of the
construct. However, one limitation of this study could be that the con-
ditions in the knee joint cavity of mice differ from those in a human
joint cavity. Therefore, further investigations are required to confirm
Table 2 Compressive mechanical properties of cartilage, according to Allan et al. [53]
In vitro-formed cartilage
(No Na-b-GP) (n = 7)
In vitro-formed cartilage
(10 mM Na-b-GP) (n = 7)
In vivo osteochondral Plugs (n = 6)
Equilibrium stress (kPa) 3.9 ± 0.6 10.5 ± 2.3 53.1 ± 9.1
Equilibrium modulus (kPa) 18.4 ± 7.8 131.3 ± 28.3 561.2 ± 87.8
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the feasibility of the ARC-HA constructs for the repair of osteochon-
dral defects in humans. Abrahamsson et al. [60] studied the effect of
culture time on the properties of 3D woven PCL scaffolds seeded with
human MSCs. In chondrogenic medium, cartilaginous tissue formed
at 3 weeks and new formed ECM were observed at the interface after
7 weeks in culture. It was confirmed that the GAG amount depended
on culture time. Furthermore, the constructs showed mechanical
properties similar to those of native articular cartilage. These results
thus are relevant when developing grafts for osteochondral defect
repair. Nevertheless, it was apparently shown that most of the above
studies used bioceramic materials as a scaffold to generate both bone
and cartilage tissues. Only bioceramic-based scaffolds, however,
might not be successful candidates for osteochondral repair because
of their hardness and lack of flexibility which polymers have. Conse-
quently, this mismatch of mechanical properties may lead to delami-
nation between the bone scaffold and new cartilage. Overcoming this
problem is suggested by using polymer/bioceramic composites as
scaffolds.
In summary, the approach involving a scaffold for the bone com-
ponent, but none for the cartilage component, can be applied to form
cartilaginous tissue on subchondral bone substrate. This scaffold type
can reduce the possible problems associated with degradation prop-
erties and biocompatibility of scaffold materials. Some studies have
shown that bilayered scaffold-free cartilage constructs exhibit in vitro
formation of cartilaginous-like tissue by chondrocytes seeded without
the aid of biomaterial support [53, 72, 74, 77]. Possible problems of
acid by-product accumulation from synthetic polymers and inflamma-
tory reactions during in vivo implantation can be thus minimized.
However, low interfacial shear strength at the interface between carti-
lage and the underlying bone scaffold is still a potentially vunerable
aspect of such systems. The formation of a mineralized layer in engi-
neered cartilage has been suggested to resolve this problem [53, 76]
considering that calcified cartilage is important for the integration of
soft tissue (nonmineralized hyaline-like cartilage) and hard tissue
(mineralized subchondral bone), and it can distribute the mechanical
load across the interface [53]. Although calcified cartilage could be
formed by this strategy, the generation of zonal organization in new
articular cartilage might be inhibited by the lack of a cartilage-like
scaffold for cell accommodation and tissue framework development.
Single and homogeneous scaffolds
This strategy uses an integrated structure for engineering the com-
plete transition between cartilage and bone layers. These scaffolds
incorporate various inclusions or coatings to form unique composite
layers in a single structure for simultaneous bone and cartilage regen-
eration (Fig. 2 (III)). Holland et al. [78] studied bilayered scaffolds for
osteochondral defects based on degradable oligo(poly(ethylene gly-
col) fumarate) (OPF) hydrogel. The scaffolds consisted of an OPF
layer as bone substrate and OPF/gelatin microparticle loaded TGF-b1
for the cartilage aspect. TGF-b1 was added to initiate the up-regula-
tion of the native chondrocytes activity. It was found that at 14 weeks
of implantation in rabbit model, hyaline cartilage with well-organized
chondrocytes and intense GAG was apparent. In addition, complete
new subchondral bone formation was observed as well as host inte-
gration evidence in the OPF bone layer. Accordingly, the quality of
repair achieved with these scaffolds confirmed their promise in
advancing cartilage repair, encouraging further in vivo investigations
with these materials. Chen et al. [79] prepared bilayered scaffolds for
osteochondral tissue engineering, combining biodegradable synthetic
polymers and naturally derived polymers. The upper layer of the scaf-
fold was collagen sponge for the cartilage portion; the underlying
layer was PLGA/collagen composite sponge for the bone portion.
SEM observation of the PLGA sponge indicated a highly porous struc-
ture (90.7% porosity) with open pores (Fig. 3A). Moreover, SEM pho-
tomicrographs confirmed the stratified structure of the bilayered
scaffold (Fig. 3B), one layer was formed by a highly porous collagen
sponge and another was a PLGA/collagen composite sponge. Also, it
was observed that the collagen sponges in the two layers were con-
A B
Fig. 3 Photos and SEM images of PLGA
sponge (A) and collagen/PLGA-collagen
bilayered sponge (B) (Reproduced from
Chen et al. [79] with the permission of
Elsevier).
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nected. The bilayered scaffolds were cultured with canine MSCs, and
then a cell/scaffold construct was implanted in an osteochondral
defect in canine knees. Histological examination of the implants indi-
cated that cartilage-like and underlying bone-like tissues were regen-
erated 16 weeks after implantation. The wettability of scaffold
surfaces is a very important factor that determines the efficiency of
cell seeding in three dimensions. It is generally difficult to deliver cell
suspensions in a manner that cells are distributed throughout porous
scaffolds made of synthetic polymers because of their hydrophobic
surfaces. Therefore, the hydrophilic properties of collagen in the col-
lagen/PLGA-collagen bilayered scaffolds were exploited to facilitate
cell seeding and to promote tissue regeneration. Oliveira et al. [80]
developed novel HA/chitosan (HA/CS) bilayered scaffolds by combin-
ing sintering and freeze drying techniques. The scaffolds were cul-
tured with MSCs for osteochondral repair. The interface of the HA/CS
bilayered scaffolds was achieved by partially impregnating the porous
ceramic layer with the polymer one. As shown in Figure 4A and B,
two distinct porous layers were observed and there was good pene-
tration of CS into the HA scaffold, which indicated good bonding
between the two layers. The pore structure of the HA layer showed
high interconnectivity with pore sizes in the range 50–500 lm
(Fig. 4C). In addition, it was possible to observe micro fibres forma-
tion in the structure of the CS layer; this could act as an additional
anchor-framework to improve cell adhesion (Fig. 4D). The mechani-
cal properties of HA/CS bilayered scaffolds were measured sepa-
rately. The compressive modulus of the HA structure (153 MPa)
indicated its suitability as a bone scaffold and the compressive modu-
lus of the CS structure (2.9 MPa) was in agreement with the value of
normal human cartilage (1.9–14.4 MPa). Moreover, in vitro cell cul-
ture studies demonstrated that both HA and CS layers provided an
adequate 3D support for attachment, proliferation and differentiation
of MSCs into osteoblasts and chondrocytes, respectively. Gotterbarm
et al. [81] studied the in vivo behaviour of bilayered scaffolds with
addition of a growth factor mixture (GFM) in deep osteochondral
defects of minipigs. Results were compared with those of untreated
defects (without constructs) and with cell-free bilayered scaffolds.
The two-layered implant consisted of a porous b-TCP substrate for
bone and a fibrous collagen type I/III layer for cartilage. It was shown
[81] that treatment with cell-free, bilayered scaffolds improved defect
filling and showed more differentiated, reparative tissue at 6 and
12 weeks after implantation. The TCP layer formed cancellous bone
within the pores at 6 weeks and the TCP scaffold completely
degraded within 52 weeks after implantation. Growth factor treatment
improved the mechanical and histomorphological properties of carti-
lage tissue at 12 weeks after implantation. The highest content of
GAG in cartilage defect was found in scaffolds incorporating growth
factors in comparison with untreated and cell-free scaffolds [81]. In
biomechanical testing, at 6, 12, and 52 weeks after implantation, the
highest axial reaction force values after stress-relaxation testing were
found after treatment with growth factors, compared with the other
treatments. These results reached the highest value at 12 weeks, but
decreased after 1 year. Although this study showed the potential ben-
efit of a cell-free, two-layered collagen-TCP construct for the repair of
large osteochondral defects, additional deposition of growth factors
improved the cartilage repair quality at 12 weeks. However, the out-
come was not significantly influenced at 1 year, possibly as a result
of degradation and depletion of the growth factors. This result
emphasizes the importance and need of longer term studies before
final assessment of the suitability of the approach. Lien et al. [82]
developed a novel osteochondral scaffold based on a ceramic-gelatin
assembly for articular cartilage repair and a porous ceramic for bone
repair. The novel scaffolds consisted of four layers: a porous ceramic
layer as bone component, a dense ceramic layer to prevent blood ves-
sel penetration and to resist shear stresses, a porous ceramic layer to
fix bone with cartilage (joining part) and a porous gelatin layer as the
cartilage facing component (Fig. 5). This scaffold design was moti-
vated from the problem of achieving improved joining strength at the
interface between cartilage and bone. Moreover, chondrocytes must
be protected from contact with blood vessels [83], so the penetration
of blood vessels from bone to cartilage must be stopped. This will
avoid excessive growth of bone and bony spur formation [84], which
can impair the function of articular cartilage. The composite scaffolds
were seeded with rat chondrocytes and found that cartilage tissue
was developed at 4 weeks of culture. GAG and DNA contents
increased with culturing time at 1, 2 and 4 weeks. After 4 weeks of
culture with chondrocytes, cells had become overgrown and very
dense, whereas at 1 week of culture, cells were seen to attach along
the surface of pores, but not yet proliferate enough to fill the pores.
At 2 weeks of culture, some cells were seen to have undergone cell





Fig. 4Macroscopic appearance and SEM
images of HA/CS bilayered scaffolds:
interface (A), typical pore at interface (B),
pore of the HA scaffold (C) and pore of
the CS layer (D) (Reproduced from
Oliveira et al. [80], with the permission of
Elsevier).
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developed at 4 weeks, and thus this scaffold approach was demon-
strated to be feasible for articular cartilage repair. Yunos et al. [85]
fabricated electrospun PDLLA fibrous coating on 45S5 Bioglass® sub-
strates, to develop a bilayered construct exhibiting rough topography
for the improvement of chondrocyte cell attachment. A fibrous sur-
face was tailored by varying the diameter of fibres via the adjustment
of electrospinning conditions, including polymer concentration, flow
rate and operating voltage. An acellular in vitro study in simulated
body fluid (SBF) showed that HA nanocrystals were formed homoge-
neously in the fibrous structure after 1 week of immersion, which
confirmed the mineralization of PDLLA fibres coated on the surface of
45S5 Bioglass® substrate. This preliminary study was an attractive
approach to combine electrospun PDLLA fibres (cartilage side) with
PDLLA-coated bioactive glass scaffold (bone side), which formed a
stratified scaffold for osteochondral tissue applications [86]. Immer-
sion bilayered PDLLA fibres/PDLLA-coated Bioglass scaffolds in
SBF for up to 4 weeks showed that HA formation was observed in the
area of interface, where was the contact between PDLLA mesh and
Bioglass® scaffold, increased the strength at the PDLLA fibre/Bio-
glass® scaffold. Therefore, the possible delamination between two
phases was avoided. As mineralized PDLLA fibres, which mimicked
the mineralized calcified cartilage, were formed, HA formation was
not observed in the PDLLA mesh. This was agreed with a requirement
that the cartilage does not mineralize [86]. Moreover, the fibrous
topography of PDLLA mesh had a potential to support the attach-
ment, growth and proliferation of a chondrocyte cell line (e.g. ATDC5
[86]). It was shown that at day 14 of cell culture, the cells started to
migrate through the pores and grow within the 3D network of the
PDLLA mesh. These preliminary results indicated that electrospun
PDLLA fibres/PDLLA-coated Bioglass® can be a suitable candidate for
osteochondral tissue engineering applications. In addition, it had been
previously shown that electrospun PDLLA fibrous structures are of
general interest in soft tissue engineering applications such as skin
regeneration [87]. Cells including fibroblasts, chondrocytes and adult
stem cells adhered and proliferated well when cultured on electrospun
scaffolds [88, 89]. In case of polylactide derived from lactic acid, the
degradation rate of electrospun scaffolds can be tailored by the differ-
ent kinds of polylactides, according to the ratio of D-, L- and D/L lac-
tide, and their molecular weights [87]. Moreover, their physical and
mechanical properties were adjusted for specific tissue applications.
Therefore, it was suggested that electrospun polylactide scaffolds are
promising candidates for cartilage tissue engineering because of the
ability to support chondrogenesis and to provide a balance between
degradation rate and mechanical stability [87, 89].
Ohyabu et al. [90] synthesized a novel porous scaffold based on a
collagen sponge incorporating HA/chondroitin sulphate composite
(pCol-HA/ChS), to form materials which resembled the ECM in bone
and cartilage. The HA/ChS composites were prepared by a precipita-
tion method and the suspension of collagen and HA/ChS was freeze-
dried to generate porous scaffolds. The combination of ChS with HA
made the HA/ChS nanocomposite to have smaller crystals and larger
surface area than pure HA. Moreover, pCol-HA/ChS composite
scaffolds showed higher porosity (95.5%) and surface area (34.5 m2/
g) than pCol (86.7% porosity and 6.52 m2/g surface area). In vitro
experiments with composite scaffolds were performed with chondro-
genic culture of MSCs. After 2 hrs of seeding, it was found that cell
adhesion on the surface and in the interior of pCol-HA/ChS scaffolds
was higher than on pCol-HA and pCol substrates because of the
rougher surface i.e. larger surface area. In addition, MSCs in the
pCol-HA/ChS composite scaffolds produced more GAG in cartilage
than in pCol-HA and pCol substrates. Therefore, it was demonstrated
that ChS included in the porous material influenced the quality of the
cartilage matrix. From these results, pCol-HA/ChS composites are
expected to be candidates for cartilage scaffolds in place of pCol. Bi
et al. [91] fabricated biphasic scaffolds for osteochondral tissue engi-
neering exhibiting a stratified structure of collagen–chitosan compos-
ite for the chondral phase and collagen–bioactive glass (58S BG)
composite for the osseous phase. The stratified scaffolds were con-
nected by cross-linked collagen integrated through pores of two
respective phases. After 1 week of seeding MSCs on the scaffold, it
was found that cells were able to spread and colonize on the scaf-
fold’s surface. Also, the spread cells maintained physical contact with
each other. This result showed that this scaffold has good biocompat-
ibility for the seeding and proliferation of MSCs.
In conclusion, single and homogeneous scaffolds are one type of
bilayered scaffolds, which are formed in a single composite construct
before cell seeding and implantation. Instead of cell-free scaffolds,
where neocartilage is generated from seeded chondrocytes on a sub-
chondral support to form cartilaginous layer, single and homoge-
neous scaffolds are designed to repair osteochondral defects by
using tailored bilayered composite structure, which mimic the struc-
ture of articular cartilage and subchondral bone tissue. The integra-
tion at the interface between engineered cartilage and the
subchondral bone part is developed via fabrication methods to form
the physical integration before cell seeding and implantation [81, 90].
Single but heterogeneous scaffolds
This category of bilayered scaffolds is composed of two distinct but
integrated layers for the cartilage and bone regions [2] (Fig. 2 (IV)),
as opposed to generating composite osteochondral grafts by combin-
ing independent cartilaginous and bone-like components. Following
this approach, Aydin et al. [92] produced osteochondral scaffolds
based on PGA woven felt for the cartilage part, collagen and HA-
coated porous PLLA/PCL foam for the bone part and PLLA/PCL layer
as the cartilage–bone interface. The pore structure of the bone
scaffold was developed by additional generation of vertical channels
to deliver stem cells and blood from bone marrow when implanted.
Fig. 5 Schematic of the design of the ceramic-gelatin assembly for
osteochondral tissue engineering, according to Lien et al. [82].
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In vitro culture of L929 mouse-fibroblast cells into osteochondral
scaffolds showed high value of cell viability and low degree of cyto-
toxicity in both cartilage and bone scaffolds. However, cell behaviours
and tissue regeneration were not shown in this study. The interface of
scaffolds was not carefully analysed in the in vitro study. Sherwood
et al. [52] developed an innovative osteochondral composite scaffold
consisting of porous D,L-PLGA/L-PLA in the form of macroscopic
staggered channels seeded with ovine articular chondrocytes for the
cartilage side and porous L-PLGA/TCP for the bone layers. The stag-
gered channels facilitated the seeding of chondrocytes into the centre
of the cartilage portion, allowed transport of nutrients to the cells and
removal of cellular and polymer degradation by-products. These com-
posite scaffolds promoted cell attachment and the formation of carti-
lage was observed after 6 weeks of in vitro culture. Cartilage and
bone parts were connected by a gradient of materials and pores,
which formed a transition region to prevent delamination after trans-
plantation. The bone region had compressive strength (2.5–
13.5 MPa) close to values of cancellous human bone, indicating that
the bone part had desirable mechanical properties for in vivo applica-
tion. Cao et al. [55] attempted to prepare osteochondral scaffolds by
designing three dimensional load-bearing structures. 3D porous PCL
scaffolds were co-cultured with osteoblasts and chondrocytes. They
found that both cell types proliferated, migrated, linked in their com-
partment, integrated at the interface, and produced different ECM
under co-culture conditions. However, the final actual phenotype of
the osteoblasts and chondrocytes in the PCL scaffolds was not
observed, for example, by DNA sequencing experiments. Schek et al.
[93] produced bilayered composite scaffolds with suitable biological
and mechanical properties by using image-based design (IBD) and
solid free-form (SFF) fabrication. The combination of these tech-
niques created scaffolds that were load-bearing and matched defect
site geometry. The two phases of the scaffolds, composed of PLLA
and HA, were assembled prior to cell seeding and implantation. These
composite scaffolds were stabilized by using two bonded cylinders of
PLLA (Fig. 6D), and a thin PGA film was deposited between the two
layers to prevent cell migration (Fig. 6A). The bilayered scaffolds
were seeded with osteogenic cells in the ceramic phase and chondro-
cytes in the cartilaginous phase. Scaffolds were then immediately
implanted in mice. Following implantation, the composite scaffolds
were seen to promote the growth of bone and cartilage, and a miner-
alized interface tissue was formed. The PLLA rods connecting the two
phases were in intimate contact with both the PLLA and HA phases
and the composite scaffolds could withstand surgical implantation.
The presence of GAG in the PLLA sponge phase was observed by
staining, indicating chondrocyte synthesis of cartilage matrix. Small
pockets of cartilage were also observed invading the pore of the cera-
mic phase. Within the pores of the HA phase, bone was observed
together with other tissues such as fibrous tissue and fat. These
results therefore demonstrated tissue formation with different cell
seeding and the development of the bone–cartilage interface on bilay-
ered composite scaffolds [93]. Ghosh et al. [94] studied porous bi-
layered scaffolds for osteochondral tissue engineering made of PLLA/
starch blends for the cartilage part and PLLA/HA or Bioglass® for the
bone part. This work considered that starch might provide capability
of water uptake and HA/Bioglass® should enhance bioactivity and HA
formation on the bone side. The interface between cartilage and sub-
chondral bone was integrated by a melt-based process. Moreover, it
was suggested that the use of PLLA in both sides was to increase the
bonding between them. The use of compression moulding followed
by particle leaching was proposed to generate porous scaffolds with
controllable porosities. For the cartilage region, a blend of PLLA and
starch exhibited adequate hydration capability and for the bone
region, PLLA reinforced with HA/Bioglass® showed the required stiff-
ness and strength. The presence of HA/Bioglass® also induced forma-
tion of a CaP layer in vitro, as expected. However, further cell culture
and in vivo studies are necessary to demonstrate that the developed
constructs could have potential to be used in regeneration of osteo-
chondral defects in realistic patient conditions. Jiang et al. [95]
improved a stratified osteochondral scaffold by focusing on the
regeneration of a calcified interface. The bilayered scaffolds based on
chondrocytes-containing agarose hydrogel for cartilage and osteo-
blasts-containing composite microspheres of PLGA and 45S5 Bio-
glass® for bone were fabricated in a cylindrical mould, and the
interface was formed by chondrocytes embedded within a hybrid
phase of gel and microspheres. An in vitro study showed that at the
integrated area, PLGA/Bioglass® composite promoted chondrocyte
mineralization and led to the formation of a calcified interface. The
construct regions were well integrated with each other and were
maintained in vitro without delamination over time. Moreover, the
chondrocytes-loaded agarose hydrogel promoted the formation of
cartilage-like ECM and the PLGA/Bioglass® composite microspheres
supported collagen deposition by osteoblasts. However, the encapsu-
lation of chondrocytes in agarose hydrogel for cartilage to improve
the mechanical properties of the construct was not successfully
achieved as the highest Young’s modulus achieved was about
20 kPa, which is still lower than that of native cartilage (0.2–0.3 GPa)
Fig. 6 Bilayered composite scaffolds produced by Schek et al. [93].
Poly-L-lactic acid (PLLA) rods were used to join the polymer and cera-
mic phases of the composite. One face of the ceramic was coated with
a thin film of poly-gamma-glutamic acid (PGA) (A). The film was
removed from the circumference and 10 ll of PLA (7.5% in methylene
chloride) was applied (B). The polymer sponge was pressed onto the
ceramic scaffold, allowing the solubilized PLLA to serve as adhesive
(C). PLLA (25% in methylene chloride) struts were extruded on two
opposite sides of the scaffold to further stabilize the composite (D)
(Reproduced from Schek et al. [93] with the permission of John Wiley
and Sons).
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[96]. To further improve the mechanical strength, future studies were
suggested to focus on utilizing biochemical factors and mechanical
stimuli. Kinikoglu et al. [97] fabricated fibre-foam bilayered scaffolds
based on elastin-like recombinamers (ELRs)/collagen fibrous mesh
and collagen porous foam. ELRs/collagen fibres were spun directly
on collagen foam, which was fabricated by freeze drying technique,
leading to the effective connection between the fibre mesh and the
surface of foams thus forming a bilayered structure. Moreover, cul-
ture of fibroblasts in ELRs/collagen fibrous mesh showed cell prolifer-
ation because of ELRs, which were enriched with short peptides
having bioactivity and also improved cell attachment.
In conclusion, single but heterogeneous scaffolds involve seeding
of different cells specifically for cartilage and bone tissues. Likewise,
single and homogeneous scaffolds, heterogeneous scaffolds are
formed before cell-seeding and implantation. The interface between
the cartilage and bone parts is developed during fabrication and lami-
nated biological integration occurs by cell growth and cell distribution
in the porous structure. In both homogeneous and heterogeneous
scaffolds, the scaffold architecture can be tailored for cell adhesion
and tissue organization, for example by, functionally graded scaffolds
with gradients in pore size, porosity and material composition to
achieve the required properties in cartilage and bone tissues. Despite
the variety of materials, scaffold designs and cells that have been
investigated for osteochondral tissue engineering, an optimal strategy
has not yet emerged. Therefore, more research efforts are needed to
find suitable combinations of materials and methodologies that can
be transferred to clinical practice.
Discussion
Many biomaterial-based approaches are being put forward which
attempt to create bilayered scaffolds suitable for regeneration of
osteochondral defects. The important purpose is to design scaffolds
that mimic the tissue of both components of the joint: cartilage and
subchondral bone. Bioactive ceramics and glasses are considered
optimal candidates for the bone component because of their mechani-
cal rigidity as well as high bone bonding ability. The polymeric phase
confers toughness and plasticity, and it is suitable as substrate for
providing the contact with cartilage tissue. Therefore, the combination
of bioceramic and polymeric phases generates suitable composite
materials with adequate biological and mechanical properties attrac-
tive for osteochondral tissue engineering. There is evidence that the
polymeric or bioceramic phases taken individually could not reach the
optimal scaffold structure and functionality required for osteochon-
dral tissue engineering. For example, Chen et al. [79] prepared a col-
lagen/PLGA-collagen stratified sponge cylinder composite to improve
the surface wettability and cell seeding efficiency because biodegrad-
able synthetic polymers have hydrophobic surfaces, which hinder cell
seeding and penetration. Cartilage-like and underlying bone-like
tissues were well integrated with surrounding tissue and in the PLGA-
collagen composite sponge portion, PLGA sponge served as the
skeleton, providing the composite with sufficient mechanical strength
while collagen formed within the pores of the PLGA sponge promoted
cell adhesion and proliferation. It was concluded [79], however, that it
is difficult to deliver cells into porous scaffolds made of biodegradable
polymers such as PLA and PLGA because of their hydrophobic sur-
faces. Thus, the combination of bioactive inorganic materials such as
HA, TCP and bioactive glasses with a polymer matrix forming com-
posite materials should overcome this problem [98]. Designed com-
posites incorporating bioactive glasses/ceramics and biodegradable
synthetic polymers seem to be well suited to generate scaffolds for
osteochondral tissue engineering. Ceramics and polymers that
degrade in vivo should be chosen for designing biocomposite scaf-
folds because, while the release of acidic degradation products from
certain polymers can cause inflammatory reactions, the basic charac-
ter of the degradation of the inorganic materials would buffer the
acidic products and should help avoid the formation of an unfavour-
able environment for cells as a result of a much decrease in pH [99].
Bioactive glasses are being highly considered for bone tissue engi-
neering scaffolds because they are highly surface reactive and can
rapidly produce HA surface layers that bond to bone in vivo [100].
Bioactive glass of composition 45S5 Bioglass® (in wt%: 45% SiO2,
24.5% Na2O, 24.4% CaO, and 6% P2O5) exposes Ca, Si, Na and P
ions, which have been shown to activate genes in osteoblast cells,
thus stimulating new bone formation in vivo [99, 101]. In addition,
bioactive glasses in porous form are biodegradable, highly osteoconduc-
tive and suitable for cell delivery. However, Bioglass® is mechanically
weak and has low fracture resistance, which causes Bioglass®-based
scaffolds to be inadequate for load bearing applications [20]. To mini-
mize their shortcomings, Bioglass® can be combined with biodegrad-
able polymers, such as PLA, PGA and PLGA, forming biodegradable
polymer/Bioglass®-based composite scaffolds [48]. Polymer coatings
improve the mechanical properties of highly porous inorganic scaf-
folds, e.g. they lead to increased work of fracture [45, 48, 75, 102].
The addition of polymers might have extra functions in the scaffold.
For example, biodegradable polymers can act as carrier for biomole-
cules and growth factors hence increasing the performance of tissue
engineering constructs. Chen et al. [45] developed 45S5 Bioglass®-
based scaffolds with improved fracture resistance by coating the
scaffolds with PDLLA. The compressive strength of PDLLA-coated
45S5 Bioglass®-based scaffolds was slightly higher compared with
uncoated scaffolds, but the work of fracture of coated foams was sig-
nificantly improved. Moreover, the bioactivity of Bioglass®-based
scaffolds was maintained after coating. Bretcanu et al. [103] studied
the biocompatibility of 45S5 Bioglass®-based scaffolds coated with
poly(3-hydroxybutyrate) (P(3HB)). It was shown that these scaffolds
were highly bioactive, as, after immersion in SBF for a few days, HA
was formed on the surface. It was also observed that P(3HB)-coated
scaffolds exhibited higher compressive strength than uncoated scaf-
folds. Moreover, the experiments confirmed that relevant cells were
able to proliferate and grow on the scaffolds. Thus, there is evidence
that the polymeric phase in polymer-coated bioceramic scaffolds is
useful to overcome the brittleness problem of bioceramic-based scaf-
folds, considering that the polymeric phase in the form of thin layers
or filaments can bridge cracks formed in the bioceramic phases [45,
99]. A major drawback of several scaffold approaches for osteochon-
dral tissue engineering is that they fail to produce a functional inter-
face between bone and cartilage. Therefore, it has been suggested
that besides designing osteochondral scaffolds and mimicking the 3D
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ECM, mimicking the characteristics of the interface between bone and
cartilage is the key challenge, given the complex nano- and macro-
architecture of the ECM [103]. Electrospinning is a promising method
for producing artificial ECM tissues for supporting cells such as
MSCs. This technique is technically feasible for the fabrication of fila-
ments ranging from the nanometre to micrometre scale, and compre-
hensive reviews are available [89, 104–108]. Synthetic polymers such
as PLA (Janjanin et al. [109], Ma et al. [110], Jeong et al. [111]),
PCL (Yoshimoto et al. [112], Shin et al. [113], Li et al. [114], Neves
et al. [115]) and PLGA (Li et al. [116], Mouthuy et al. [117]), and nat-
ural polymers such as collagen (Song et al. [118]), fibrinogen and
poly(hydroxyalkanoates) (PHB, PHBV, P4HB, PHBHHx, PHO) (Bret-
canu et al. [103]), have been processed by electrospinning into
fibrous non-woven scaffolds to support cell growth and differentiation
[119, 120]. Srouji et al. [121] prepared 3D nanofibrous multilayered
scaffolds to mimic natural ECM by using electrospinning of PCL and
bovine collagen type I for MSCs support. It was found that the novel
3D nanofibre multilayered constructs are able to contain efficient cell
mass necessary for successful in vivo grafting. Jeong et al. [111]
produced nanofibrous PLA/nano-HA composite scaffolds by using
electrospinning technique for guided bone tissue regeneration. The
polymer coating on bioceramic composites limits the exposure of the
bioceramic on the surface of the scaffold, decreasing the chance that
cells make contact with the bioactive component. Nanosized features
of electrospun scaffolds have demonstrated an assembly of non-
woven macro/nanofibres mimicking the structure of natural ECM. The
incorporation of HA nanoparticles showed the formation of smooth
nanofibres with high pore volume and interconnecting pores. An in vi-
tro cell culture study, in which pre-osteoblasts (MC3T3-E1) were used
as a model cell type, showed that cells maintained viability and prolif-
erated continuously up to 3 weeks, indicating that PLA/HA nanofibres
are effective scaffolds for the growth of pre-osteoblasts. Moreover,
these composite scaffolds showed promise as a temporary substrate
for osteoblast culture in guided regeneration of bone tissue. Electro-
spun PLLA/nano-HA composite fibrous scaffolds for bone tissue
engineering were also studied by Chuenjitkuntaworn et al. [122].
Their potential as substrates for bone cell culture was assessed. The
porosity of these fibrous scaffolds was high (97–98%). In vitro stud-
ies were carried out in which PLLA/HA fibrous scaffolds were cultured
with MC3T3-E1 mouse pre-osteoblastic cells. The results showed that
the presence of HA in PLLA fibrous scaffolds not only promoted
attachment and proliferation of pre-osteoblastic cells but also
increased the extent of mineralization after 3 weeks culture. Song
et al. [118] studied collagen-apatite nanocomposite scaffolds for
bone regeneration by using electrospinning technique. They con-
cluded that electrospun fibrous layers of collagen-apatite nanocom-
posite might be useful as a cell supporting substrate for bone
regeneration, but the materials were not studied for cartilage repair. A
study of 3D nanofibrous scaffolds for cartilage tissue was presented
by Li et al. [114]. They fabricated a nanofibrous scaffold made of PCL
and examined the ability of the scaffold to support chondrogenesis of
MSCs in vitro in the presence of TGF-b. The morphological analysis
showed that 3D MSC-seeded constructs displayed a cartilage-like
morphology, containing chondrocyte-like cells surrounded by carti-
laginous matrix. Quantitative biochemical assays also confirmed the
continuous synthesis of GAG during the 3 weeks of culture time.
Because biodegradable nanofibrous scaffolds have a high surface to
volume ratio, they provide a favourable 3D porous space to accom-
modate cells at high density. It was demonstrated that MSCs seeded
and cultured in nanofibrous PCL scaffolds successfully undergo
chondrogenesis in vitro [114, 123]. It was proposed therefore that 3D
nanofibrous PCL scaffolds are suitable candidate bioactive carriers
for MSCs transplantation in tissue engineering-based cartilage repair.
Thorvaldsson et al. [119] studied the electrospinning technique to
produce porous scaffolds for cartilage regeneration. The electrospin-
ning technique was used to coat single microfibres with nanofibres.
Nanofibrous PLA-coated microfibrous PCL scaffolds exhibited the
combined benefits of tailored porosity (95–97%) for cellular infiltra-
tion and nanostructured surface morphology for cell growth. More-
over, the 3D structure of electrospun scaffolds allowed cells to fully
differentiate, leading to maintenance of normal cell activity that is not
possible in 2D environments. These nanofibre-coated microfibre scaf-
folds with pore sizes of ~100 lm showed a significant improvement
in cellular infiltration. Janjanin et al. [109] evaluated the potential of
using MSCs seeded into electrospun PLLA scaffolds, which were then
cultured in a bioreactor to engineer cartilage. Chondrogenesis was
induced with TGF-b1 or IGF-I. The constructs showed formation of
hyaline cartilage, tissue integrity and shape retention after 42 days’
culture. Cartilage matrix gene expression and amount of GAG were
seen after 42 days’ culture and increased with time. Therefore, these
nanofibrous scaffolds were confirmed to be applicable as a highly
functional biomaterial matrix supporting cell distribution, efficient cell
differentiation and ECM expression. In a related investigation, Mou-
thuy et al. [117] investigated the potential of the electrospinning tech-
nique to prepare 3D PLGA/collagen-containing nano-HA constructs,
mimicking the zonal organization of the bone–cartilage interface. It
was shown that fibre membranes produced by electrospinning could
mimic the ECM and they could be used as a support for tissue cul-
ture. Moreover, electrospun membranes could be tailored in terms of
architecture and composition to optimize cell response. The presence
of collagen and HA increased the biocompatibility of scaffolds, also
enhancing their stiffness and hydrophilicity. Chitosan/PCL blend fibre
mesh scaffolds were studied for cartilage repair by Neves et al. [115].
Microfibres were obtained by wet-spinning and then these fibres were
folded into cylindrical moulds and underwent thermal treatment to
obtain the scaffolds. The PCL component led to a higher fibre surface
roughness and increased compressive strength of the scaffolds. In
terms of biological behaviour, after culturing bovine articular chon-
drocytes, cartilaginous ECM formation was observed and the scaf-
folds supported neocartilage formation, as demonstrated by an
increase in GAG production. Overall, electrospinning is a promising
technique that produces polymeric fibrous structures comparable to
the ECM of many tissues. Interestingly, nanofibrous scaffolds adsorb
more selective proteins than solid walled scaffolds, indicating
enhancement of cell adhesion [124]. Additionally, electrospinning is a
simple and versatile processing method that enables the control of
fibre size and orientation by varying polymer concentration, solvent
optimization and processing parameters. However, fabricating 3D
shapes and controlling porosity and pore shape are remaining chal-
lenges that have limited the further use of electrospinning in tissue
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engineering applications [125, 126, 127]. To fabricate 3D fibrous
scaffolds, a collector plate can be replaced with a rotating cylinder
[127] or a 3D columnar collector [128], or the fibrous meshes can be
rolled up to produce a tubular scaffold [126]. It is also well known
that the small pore size produced by electrospinning limits cellular
infiltration and tissue ingrowth into fibrous scaffolds. Diverse tech-
niques are being developed to overcome this problem such as varia-
tion of electrospinning parameters, use of rotating collector and
application of wet electrospinning, as reviewed by Kovacina et al.
[129] and Teo et al. [130]. For example, the porosity of electrospun
meshes in 3D can be increased by using a salt leaching method
[126]. In addition, vapour or heat treatment [126] can be applied to
improve the mechanical properties of electrospun fibrous meshes.
Indeed, technological advances in electrospinning are expected to
enhance its applications in tissue engineering scaffold production.
Besides the discussed electrospinning process, fibres can be gener-
ated also by alternative techniques. For example, Steck et al. [131]
and Reiband et al. [132] produced scaffolds by using flock technol-
ogy, which is based on electrostatic application of fibres fed onto vari-
ous material surfaces that are covered by an adhesive [132]. Flocking
applies short fibres (0.3–5 mm in length) to a substrate, the fibres
being aligned in an electrostatic field and accelerated towards the
adhesive-covered substrate [132]. Reaching the adhesive, the fibres
are fixed in perpendicular direction to the substrate providing a uni-
form flock coating [133]. In the study of Steck et al. [131], aniso-
tropic scaffolds for cartilage repair composed of collagen type I as
substrate, gelatin as adhesive and parallel-oriented polyamide fibres
arranged vertically to the substrate supported a cartilaginous pheno-
type in vitro. The results showed that MSCs adhered and proliferated
well on the scaffolds and cell vitality remained high over time. Proteo-
glycans and collagen type II were observed in the flock scaffolds
seeded with chondrocytes, indicating that these scaffolds could be
appropriate candidates for cartilage repair. Moreover, in terms of
mechanical properties, flock scaffolds exhibited higher initial hard-
ness than a clinically applied collagen scaffold, which increased fur-
ther in MSC-loaded flock composites during chondrogenesis.
However, these scaffolds have not been studied in vivo yet. While the
cartilage component of osteochondral constructs is designed as a
blood vessel-free tissue substitute analogue to native avascular carti-
lage, an additional challenge for engineering the bone part has to be
addressed in the future: vascularization strategies for in vivo integra-
tion of the engineered bone part. Although osteointegration of smaller
constructs might be successful, initial perfusion of central parts
within larger bone constructs after transplantation may be insufficient
to provide cell survival. Thus, pre-vascularization may be deemed
necessary when it comes to in vivo application of larger osteochon-
dral bone constructs or when such a construct is implanted in a reci-
pient site with reduced blood flow (following irradiation or chronic
infection, e.g.). Different approaches to vascularization in the field of
bone tissue engineering have been pursued in the past. Tanaka et al.
[133] established a microsurgical animal model, the rat “AV-loop
model”, as a promising approach for tissue engineering purposes,
facilitating the generation of axially vascularized tissue. In contrast to
randomly vascularized tissue constructs, axially vascularized constructs
can be transplanted with re-connection of their central vascular axis
to blood vessels at the recipient site, thus providing sufficient blood
supply even to central parts of the tissue engineered construct imme-
diately after its transplantation. In the subsequent years this strategy
has evolved in the field of bone tissue engineering with application of
different bone substitutes in the rat AV-loop [134] as well as trans-
plantation of osteoblastic cells [135] and administration of angiogenic
growth factors [136]. To transfer tissue engineering developments
from bench to bedside, scaling up of established small animals mod-
els and developing new large animal models are the next consequent
steps towards future clinical application. Cheng et al. [137], for
example, described the generation of a vascularized bone construct
in vivo by implanting an isolation chamber filled with bone substitute
directly over the cambium layer of the rib periosteum in a large
animal sheep model. The small animal rat AV-loop model has also
been translated to large animal models: axial vascularization of differ-
ent bone substitutes as tissue engineering matrices was demon-
strated in a newly developed sheep AV-loop model [138, 139].
Eweida et al. [140] proposed a different model for generation of
axially vascularized bone constructs: an AV-loop model in the goat,
based on its facial vessels. While successful axial vascularization of
bone constructs was achieved in these different models, generation
and transplantation of functional bone tissue with appropriate biome-
chanical properties still have to be shown. In this context, vasculariza-
tion strategies developed for pure bone tissue engineering may also
play a crucial role for future in vivo application of large osteochondral
tissue constructs.
Conclusions
By describing the wide variety of approaches being investigated for
osteochondral tissue engineering, numerous challenges are high-
lighted, which are associated with defect site, physicochemical/
mechanical properties of materials, cell types and interaction between
them, as well as interaction between scaffolds and native tissue.
These challenges are also influenced by the complexity of interface
tissue composition and properties because of the required integration
of cartilage and underlying subchondral bone, which exhibit
significantly different biomechanical structure and functional proper-
ties. Based on the particular structure to be regenerated in this branch
of interface tissue engineering, bilayered composite scaffolds are
being developed with the aim to facilitate the temporary mimicking of
the local tissue organization at the interface between both tissues.
The pore structure of scaffolds is an important factor for cell differen-
tiation and proliferation, and for regeneration of new tissue. The opti-
mized size of pore interconnection of cartilaginous scaffolds should
be less than that of subchondral bone scaffolds because articular car-
tilage is normally fed by articular fluid, whereas bone is fed by the
nutrients from blood circulation [73]. The porous structure of scaf-
folds can be tailored via carefully developed material fabrication meth-
ods. Moreover, an appropriate biomaterial for cartilage repair must be
compressible and flexible to avoid damage of host cartilage in contact
with the engineered scaffold. However, engineered scaffolds must
have enough mechanical strength to maintain long-term stability.
Another important factor to be considered is to develop cartilage–
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bone interfaces that do not delaminate after implantation. Strong car-
tilage–bone interfaces can be generated by promoting biological and
physical integration, both in vitro and in vivo. In terms of biological
integration, many approaches have shown that cartilage and bone lay-
ers can be connected by new formed ECM from chondrocyte-seeded
scaffolds. In addition, it is suggested that the formation of zonal orga-
nization in neocartilage is necessary for a successful integration of
the interface, following the fact that mineralized calcified layer is the
interface, which connects hyaline articular cartilage and subchondral
bone. The local formation of neocartilage depends on the interaction
between chondrocytes and the engineered cartilaginous component,
which depends on surface chemistry and topography of the scaffold,
as well as on pore size and porous structure, and on the degradation
rate of the biomaterials used. In terms of physical integration, the
interfacial shear strength of bilayered scaffolds can be improved by
the binding interaction between the respective scaffolds for cartilage
and bone tissues before cell seeding and implantation. In some stud-
ies, scaffolds for cartilage and bone are connected by using additional
glues such as fibrin glue and polymer thin films to stabilize the
bilayered structures for in vitro and in vivo studies. Novel strategies
suggest the possibility to connect distinct layers forming a connected
stratified scaffold by using polymer–polymer bonding, infiltration of
polymer into porous bioceramic scaffold, and simultaneous adjust-
ment of fabrication techniques. However, the ideal bilayered scaffold
for osteochondral tissue engineering has not been developed yet. The
clinical relevance in this area is in progress as well. Indeed, osteo-
chondral tissue engineering is at the very interface of several research
areas including materials science, cell and molecular biology and clin-
ical medicine. According to the basic components discussed, besides
cell seeding on scaffolds for chondrogenic and osteogenic potential,
the incorporation of specific growth factors is a promising option to
regulate cell differentiation and also to improve the mechanical prop-
erties of the cartilage repair tissue after implantation. Selection of
specific cell types for seeding into scaffolds depends on the applica-
tion and material structure. Osteochondral repair involves significant
challenges as osteochondral constructs must avoid the risk of cell
phenotypic changes and the regeneration of neo-cartilage tissue must
achieve the structural organization of the native tissue. In this context,
the consideration of in vivo studies in appropriate small and large ani-
mal models with variation in defect thickness is needed to investigate
integration ability of scaffolds, vascularization of the bone part, possi-
ble inflammatory response and long-term stability to translate in vitro
data into clinically relevant approaches.
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